Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy
Clinical trial NCT05243823 · COMPLETED
Trial details
- NCT number
- NCT05243823
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-15
- Primary completion
- 2022-07-31
- Enrollment
- 500000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.